Frontiers in Pharmacology | Respiratory Pharmacology

Original Research

Published on 13 Sep 2024

Aspirin reduces the mortality risk of patients with community-acquired pneumonia: a retrospective propensity-matched analysis of the MIMIC-IV database

in Respiratory Pharmacology

Guangdong Wang
Jiaolin Sun
Yaxin Zhang
Na Wang
Tingting Liu
Wenwen Ji
Lin Lv
Xiaohui Yu
Xue Cheng
Mengchong Li

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1402386

4,848 views
1 citation

Original Research

Published on 11 Sep 2024

Triiodothyronine acts on DAO to regulate pulmonary fibrosis progression by facilitating cell senescence through the p53/p21 signaling pathway

in Respiratory Pharmacology

Xiaoshu Guo
Kai Xu
Lan Wang
Linke Ding
Wenwen Li
Xinsheng Zhang
Weiming Zhao
Ningdan Wang
Gaiping Wang
Wenyu Zhao

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1433186

1,851 views
1 citation

Original Research

Published on 06 Sep 2024

Dopamine, norepinephrine, and vasopressin accelerate particle transport velocity in murine tracheal epithelium via substance-specific receptor pathways: dependency on intra- and extracellular Ca2+ sources

in Respiratory Pharmacology

Götz Schmidt
Isabelle Greif
Sabrina Müller
Melanie Markmann
Fabian Edinger
Michael Sander
Christian Koch
Michael Henrich

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1401983

1,318 views
1 citation

Review

Published on 30 Aug 2024

Lung fibrosis in sarcoidosis. Is there a place for antifibrotics?

in Respiratory Pharmacology

Karol Bączek
Wojciech Jerzy Piotrowski

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1445923

4,733 views
3 citations

Original Research

Published on 27 Aug 2024

Developing a predictive nomogram for mortality in patients with extrapulmonary acute respiratory distress syndrome: the prognostic value of serum soluble thrombomodulin, lung ultrasound score, and lactate

in Respiratory Pharmacology

Yang Yang
Yue Wang
Guoguo Zhu
Siya Xu
Jie Liu
Zhongzhi Tang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1407825

1,143 views

Review

Published on 22 Aug 2024

Pharmacological profile of dicaffeoylquinic acids and their role in the treatment of respiratory diseases

in Respiratory Pharmacology

Matthias Hufnagel
André Rademaekers
Anika Weisert
Hanns Häberlein
Sebastian Franken

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1371613

2,288 views
3 citations

Review

Published on 20 Aug 2024

Role of mitochondria in inflammatory lung diseases

in Respiratory Pharmacology

Venkata Ramireddy Narala
Sahithi Reddy Narala
Parasuraman Aiya Subramani
Kalpana Panati
Narasaiah Kolliputi

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1433961

3,925 views
8 citations

Correction

Published on 12 Aug 2024

Corrigendum: Extracellular HSP90α interacts with ER stress to promote fibroblasts activation through PI3K/AKT pathway in pulmonary fibrosis

in Respiratory Pharmacology

Jinming Zhang
Wenshan Zhong
Yuanyuan Liu
Weimou Chen
Ye Lu
Zhaojin Zeng
Yujie Qiao
Haohua Huang
Xuan Wan
Wei Li

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1296214

1,158 views

Original Research

Published on 09 Aug 2024

Safety, effectiveness, and usefulness of higher-dose tablets of generic pirfenidone in patients with IPF: a nationwide observational study in South Korea

in Respiratory Pharmacology

Jieun Kang
Kwan Ho Lee
Jae Ha Lee
Yi Yeong Jeong
Sun Mi Choi
Ho Cheol Kim
Joo Hun Park
Hyun-Kyung Lee
Suk Joong Yong
Hye Sook Choi

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1451447

3,693 views

Original Research

Published on 08 Aug 2024

Long-term effects of mepolizumab in patients with severe eosinophilic asthma: a 6-year real-life experience

in Respiratory Pharmacology

Anna Agnese Stanziola
Claudio Candia
Gerardo Nazzaro
Antonio Caso
Claudia Merola
Lorena Gallotti
Mauro Maniscalco

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1449220

3,224 views
3 citations

Original Research

Published on 07 Aug 2024

CKD-497 inhibits NF-kB signaling and ameliorates inflammation and pulmonary fibrosis in ovalbumin-induced asthma and particulate matter-induced airway inflammatory diseases

in Respiratory Pharmacology

Hyejeong Kim
Jihye Choi
Jaeok Seo
Hyungjoon Lim
Sung Kwon Kang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1428567

2,599 views

Review

Published on 23 Jul 2024

Role and regulators of N6-methyladenosine (m6A) RNA methylation in inflammatory subtypes of asthma: a comprehensive review

in Respiratory Pharmacology

Ge Gao
Yu Qiu Hao
Chen Wang
Peng Gao

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1360607

2,202 views
3 citations

Original Research

Published on 18 Jul 2024

Effect of different sedatives on the prognosis of patients with mechanical ventilation: a retrospective cohort study based on MIMIC-IV database

in Respiratory Pharmacology

Xiaoding Shi
Jiaxing Zhang
Yufei Sun
Meijun Chen
Fei Han

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1301451

4,756 views
1 citation

Original Research

Published on 18 Jul 2024

Exploring the associations between elevated plasma SP-D levels and OSCAR gene expression as potential biomarkers in patients with COPD: a cross-sectional study

in Respiratory Pharmacology

Saima Mukhtar
Nakhshab Choudhry
Saqib Saeed
Asif Hanif
Aamir J. Gondal
Nighat Yasmin

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1376394

1,419 views

Editorial

Published on 09 Jul 2024

Editorial: Molecular pharmacological approaches against lung diseases: targeted drug discovery

in Respiratory Pharmacology

Poonam Arora
Lalit Mohan Nainwal
Seyyed Shamsadin Athari

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1419138

1,120 views

Methods

Published on 01 Jul 2024

A novel in vitro cell model of the proteinase/antiproteinase balance observed in alpha-1 antitrypsin deficiency

in Respiratory Pharmacology

Celine H. Chen
Helena Crisford
Aaron Scott
Elizabeth Sapey
Robert A. Stockley

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1421598

1,780 views
1 citation